MYL6 has a poor prognosis with high expression in eight tumor types (GBMLGG, LGG, ACC, UVM, LAML, MESO, STES, STAD) and a poor prognosis with low expression in four tumor types (SARC, KIRC, THYM, OV) (Figure 6D). This evidence concerns the gene MYL6 and neoplasm.